Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
| Total reported revenue | 22.7M | 23.7M | 11.1M | 20.0M |
| Cost of revenue | 10.4M | 6.7M | 6.5M | 14K |
| Gross profit | 12.3M | 17.0M | 4.6M | 20.0M |
| Operating expense | ||||
| Research & development | -2.5M | — | -2.6M | — |
| Selling general and admin | — | — | — | -7.5M |
| Other operating expenses | 5.7M | 5.5M | 3.5M | 4.6M |
| Operating income | 4.9M | 9.0M | -3.6M | 8.3M |
| Non operating interest income | ||||
| Income | 0 | — | 62K | 0 |
| Expense | 11K | 625K | 17K | 841K |
| Other income expense | — | — | — | — |
| Pretax income | 4.0M | 8.4M | -3.6M | 7.5M |
| Tax provision | 724K | 694K | 0 | 416K |
| Net income | 3.3M | 7.7M | -3.6M | 7.1M |
| Basic EPS | 0.3 | 0.7 | -0.3 | 0.6 |
| Diluted EPS | 0.3 | 0.7 | -0.3 | 0.6 |
| Basic average shares | 12.5M | 10.8M | 12.5M | 12.5M |
| Diluted average shares | 13.0M | 11.2M | 12.5M | 12.5M |
| EBITDA | 4.2M | 9.2M | -3.4M | 8.5M |
| Net income from continuing op. | 4.9M | 9.0M | -3.6M | 8.3M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |